-
Something wrong with this record ?
PML protein association with specific nucleolar structures differs in normal, tumor and senescent human cells
Janderová-Rossmeislová L, Nováková Z, Vlasáková J, Philimonenko V, Hozák P, Hodný Z.
Language English Country United States
- MeSH
- Cell Nucleolus chemistry ultrastructure MeSH
- Cell Line MeSH
- Fibroblasts cytology MeSH
- Financing, Organized MeSH
- Microscopy, Fluorescence MeSH
- HeLa Cells MeSH
- Nuclear Proteins analysis metabolism MeSH
- Humans MeSH
- Mesenchymal Stem Cells cytology MeSH
- Cell Line, Tumor MeSH
- Neoplasm Proteins analysis metabolism MeSH
- Tumor Suppressor Proteins analysis metabolism MeSH
- Neoplasms pathology MeSH
- Cellular Senescence MeSH
- Transcription Factors analysis metabolism MeSH
- Protein Transport MeSH
- Check Tag
- Humans MeSH
Promyelocytic leukemia protein (PML), a tumor suppressor, forms in most human cell types discrete multiprotein complexes termed PML nuclear bodies. Here, we have used indirect immunofluorescence and confocal microscopy to describe various forms of a novel nuclear PML compartment associated with nucleoli that is found under growth-permitting conditions in human mesenchymal stem cells (hMSC) and skin fibroblasts but not in several immortal cell lines with defects in the p53 and pRb pathways. In addition, we found that shut-off of rRNA synthesis induced by actinomycin D causes PML translocation to the surface of segregated nucleoli. This translocation is dynamic and reversible, following changes in nucleolar activity. Intriguingly, treatment causing premature senescence restores PML binding to nucleoli-derived structures and to the surface of segregated nucleoli in HeLa cells. These findings indicate that PML may be involved in nucleolar functions of normal non-transformed or senescent cells. The absence of nucleolar PML compartment in rapidly growing tumor-derived cells suggests that PML association with the nucleolus might be important for cell-cycle regulation.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10000612
- 003
- CZ-PrNML
- 005
- 20130129164318.0
- 008
- 100112s2007 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Rossmeislová, Lenka $7 xx0095550
- 245 10
- $a PML protein association with specific nucleolar structures differs in normal, tumor and senescent human cells / $c Janderová-Rossmeislová L, Nováková Z, Vlasáková J, Philimonenko V, Hozák P, Hodný Z.
- 314 __
- $a Department of Cell Ultrastructure and Molecular Biology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídenská 1083, 142 20 Prague 4, Czech Republic
- 520 9_
- $a Promyelocytic leukemia protein (PML), a tumor suppressor, forms in most human cell types discrete multiprotein complexes termed PML nuclear bodies. Here, we have used indirect immunofluorescence and confocal microscopy to describe various forms of a novel nuclear PML compartment associated with nucleoli that is found under growth-permitting conditions in human mesenchymal stem cells (hMSC) and skin fibroblasts but not in several immortal cell lines with defects in the p53 and pRb pathways. In addition, we found that shut-off of rRNA synthesis induced by actinomycin D causes PML translocation to the surface of segregated nucleoli. This translocation is dynamic and reversible, following changes in nucleolar activity. Intriguingly, treatment causing premature senescence restores PML binding to nucleoli-derived structures and to the surface of segregated nucleoli in HeLa cells. These findings indicate that PML may be involved in nucleolar functions of normal non-transformed or senescent cells. The absence of nucleolar PML compartment in rapidly growing tumor-derived cells suggests that PML association with the nucleolus might be important for cell-cycle regulation.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a stárnutí buněk $7 D016922
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a buněčné jadérko $x chemie $x ultrastruktura $7 D002466
- 650 _2
- $a fibroblasty $x cytologie $7 D005347
- 650 _2
- $a HeLa buňky $7 D006367
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mezenchymální kmenové buňky $x cytologie $7 D059630
- 650 _2
- $a fluorescenční mikroskopie $7 D008856
- 650 _2
- $a nádorové proteiny $x analýza $x metabolismus $7 D009363
- 650 _2
- $a nádory $x patologie $7 D009369
- 650 _2
- $a jaderné proteiny $x analýza $x metabolismus $7 D009687
- 650 _2
- $a transport proteinů $7 D021381
- 650 _2
- $a transkripční faktory $x analýza $x metabolismus $7 D014157
- 650 _2
- $a nádorové supresorové proteiny $x analýza $x metabolismus $7 D025521
- 700 1_
- $a Nováková, Zora. $7 _AN031782
- 700 1_
- $a Vlasáková, Jana. $7 _AN040745
- 700 1_
- $a Filimonenko, Vlada $7 xx0085326
- 700 1_
- $a Hozák, Pavel, $d 1958- $7 js20040517003
- 700 1_
- $a Hodný, Zdeněk $7 xx0074117
- 773 0_
- $w MED00002951 $t Journal of structural biology $g Roč. 159, č. 1 (2007), s. 56-70 $x 1047-8477
- 910 __
- $a ABA008 $b x $y 8
- 990 __
- $a 20090310084605 $b ABA008
- 991 __
- $a 20100112142857 $b ABA008
- 999 __
- $a ok $b bmc $g 703341 $s 565780
- BAS __
- $a 3
- BMC __
- $a 2007 $b 159 $c 1 $d 56-70 $i 1047-8477 $m Journal of structural biology $x MED00002951
- LZP __
- $a 2010-b1/ipme